Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (2,957,601)	$ (259,537)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expense	237	237
Accretion of origination fee income		(6,870)
Amortization of deferred loan costs		35,430
Payroll protection loan forgiveness		(20,927)
Changes in operating assets and liabilities:
Increase in judgments payable	1,518,000
Increase in settlements payable	1,000,000
Increase in interest receivable		(50,139)
Increase in accrued management fees - related party	112,500	112,500
Decrease in accounts payable and accrued expenses	195,965	(19,909)
Increase in interest payable	2,100
Increase in notes payable - related party	19,688	13,125
Net cash used in operating activities	(109,111)	(196,090)
Cash Flows from Investing Activities:
Net cash from investing activities
Cash Flows from Financing Activities:
Proceeds from short term loan	35,000
Proceeds from stockholder contribution	73,650	191,211
Net cash provided by (used in) financing activities	108,650	191,211
Net increase (decrease) in cash	(461)	(4,879)
Cash and restricted cash at beginning of year	588	11,624
Cash and restricted cash at end of year	127	6,745
Supplemental Disclosure of Cash Flow Information:
Interest
Income Taxes
Schedule of Non-Cash Investing and Financing Activities:
Distribution due to non-controlling interest	90,000	90,000
Amortization of discount on redeemable preferred stock	$ 17,766	$ 17,766